Lv11
19 积分 2021-05-13 加入
Global burden and cross-country inequalities in six major immune-mediated inflammatory diseases from 1990 to 2021: A systemic analysis of the Global Burden of Disease Study 2021
3小时前
已完结
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
3小时前
已完结
Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects
3小时前
已完结
Peptide GLP-1 receptor agonists: From injection to oral delivery strategies
6天前
已完结
Transforming obesity: The advancement of multi-receptor drugs
7天前
已完结
Emerging trends in IRAK-4 kinase research
8天前
已完结
Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer
8天前
已完结
GLP-1-based therapies for diabetes, obesity and beyond
8天前
已完结
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
11天前
已完结
Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?
12天前
已完结
皖公网安备34019202002308
